These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32517762)

  • 1. C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro.
    Chen WX; Liu HH; Li RX; Mammadov G; Wang JJ; Liu FF; Samadli S; Wu YF; Zhang DD; Luo HH; Hu P
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):46. PubMed ID: 32517762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The downstream RAF-1 signaling of fibroblast growth factor-23 participates in the osteogenetic effect caused by C-type natriuretic peptide in vitro.
    Li RX; Chen WX; Liu HH; Fan GZ; Qiu Z; Jiang Q; Wu YF; Zhang DD; Luo HH; Hu P
    Adv Med Sci; 2021 Mar; 66(1):206-214. PubMed ID: 33735829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes.
    Tang KT; Capparelli C; Stein JL; Stein GS; Lian JB; Huber AC; Braverman LE; DeVito WJ
    J Cell Biochem; 1996 Apr; 61(1):152-66. PubMed ID: 8726364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-Type natriuretic peptide/guanylate cyclase B system in rat osteogenic ROB-C26 cells and its down-regulation by dexamethazone.
    Suda M; Komatsu Y; Tanaka K; Yasoda A; Sakuma Y; Tamura N; Ogawa Y; Nakao K
    Calcif Tissue Int; 1999 Dec; 65(6):472-8. PubMed ID: 10594167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone.
    Teerapornpuntakit J; Wongdee K; Krishnamra N; Charoenphandhu N
    Cell Biol Int; 2016 Mar; 40(3):329-40. PubMed ID: 26694880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Type Natriuretic Peptide Dampens Fibroblast Growth Factor-23 Expression Through MAPK Signaling Pathway in Human Mesangial Cells.
    Wu YF; Zhang DD; Liu SY; Luo HH; Jiang GM; Xu Y; Wu Y; Wang JJ; Liu FF; Samadli S; Wei W; Hu B; Hu P
    J Interferon Cytokine Res; 2018 Nov; 38(11):500-509. PubMed ID: 30335543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
    Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
    Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide affects bone remodeling by effects on osteoblast differentiation and function.
    Hu YC; Cheng HL; Hsieh BS; Huang LW; Huang TC; Chang KL
    Bone; 2012 Jun; 50(6):1406-15. PubMed ID: 22465848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.
    Debiais F; Hott M; Graulet AM; Marie PJ
    J Bone Miner Res; 1998 Apr; 13(4):645-54. PubMed ID: 9556064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.
    Hu P; Huang BY; Xia X; Xuan Q; Hu B; Qin YH
    J Recept Signal Transduct Res; 2016; 36(2):213-9. PubMed ID: 26459742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation.
    Yeh LC; Zavala MC; Lee JC
    J Cell Biochem; 2006 Feb; 97(3):494-500. PubMed ID: 16187313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling.
    Zhang DD; Wu YF; Chen WX; Xu Y; Liu SY; Luo HH; Jiang GM; Wu Y; Hu P
    Exp Mol Med; 2019 Jul; 51(7):1-18. PubMed ID: 31263178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.
    Lozano D; Feito MJ; Portal-Núñez S; Lozano RM; Matesanz MC; Serrano MC; Vallet-Regí M; Portolés MT; Esbrit P
    Acta Biomater; 2012 Jul; 8(7):2770-7. PubMed ID: 22487933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8.
    Valta MP; Hentunen T; Qu Q; Valve EM; Harjula A; Seppänen JA; Väänänen HK; Härkönen PL
    Endocrinology; 2006 May; 147(5):2171-82. PubMed ID: 16439448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells.
    Inoue A; Hayakawa T; Otsuka E; Kamiya A; Suzuki Y; Hirose S; Hagiwara H
    J Biochem; 1999 Jan; 125(1):103-8. PubMed ID: 9880804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system.
    Suda M; Tanaka K; Fukushima M; Natsui K; Yasoda A; Komatsu Y; Ogawa Y; Itoh H; Nakao K
    Biochem Biophys Res Commun; 1996 Jun; 223(1):1-6. PubMed ID: 8660352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 promotes osteogenic differentiation and collagen I alpha 2 synthesis via induction of mRNA-binding protein LARP6 expression.
    Guo Y; Tang CY; Man XF; Tang HN; Tang J; Zhou CL; Tan SW; Wang M; Feng YZ; Zhou HD
    Dev Growth Differ; 2017 Feb; 59(2):94-103. PubMed ID: 28211947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells.
    Hagiwara H; Inoue A; Yamaguchi A; Yokose S; Furuya M; Tanaka S; Hirose S
    Am J Physiol; 1996 May; 270(5 Pt 1):C1311-8. PubMed ID: 8967430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.